Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder — Stella

Home/Major Depressive Disorder (MDD)/Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

View on ClinicalTrials.gov

Recruiting

Back to Major Depressive Disorder (MDD) trials

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Collaborative Neuroscience Network, Garden Grove, California

Key details

Phase

Safety & dosing

Sponsor

Supernus Pharmaceuticals, Inc.

Enrollment target

~230 participants

Started

January 2026

Primary completion

December 2026

Age range

18 Years – 70 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.